GSK Tells 3rd Circ. To Uphold Dismissal Of Avandia Suit
GlaxoSmithKline LLC asked the Third Circuit to cement its win on Friday over allegations the company bilked patients by selling its diabetes drug Avandia without disclosing associated heart risks, saying the...To view the full article, register now.
Already a subscriber? Click here to view full article